section name header
Index
Aromatase Inhibitors for Treatment of Advanced Breast Cancer in Postmenopausal Women
Benign Gynaecological Lesions and Tumours
Combination Injectable Contraceptives for Contraception
Combined Oral Contraceptives and Bone Mineral Density
Combined Oral Contraceptives and Bone Mineral Density
Danazol in the Treatment of Endometriosis
Effect of Peri- and Postmenopausal Hormone Replacement Therapy on Body Weight
Endometriosis
Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
High-Dose Progestins for the Treatment of Cancer Anorexia-Cachexia Syndrome
Hormonal Therapy in Advanced or Recurrent Endometrial Cancer
Hormone Replacement Therapy for Cognitive Function in Postmenopausal Women
Immediate Start of Hormonal Contraceptives for Contraception
Intrauterine Device for Contraception
Levonorgestrel Intrauterine System Vs. other Forms of Reversible Contraceptives
Levonorgestrel-Releasing Intrauterine Device (LNG-IUD) for Symptomatic Endometriosis Following Surgery
List of Abbreviations
Long Acting Progestin Contraceptives and Bone Mineral Density
Medical Therapy for Endometriosis Surgery
Menopausal Hormone Therapy and Breast Cancer
Menopausal Symptoms and Hormone Therapy
Oral Contraceptives in the Treatment of Endometriosis
Palliative Treatment
Postmenopausal Hormone Therapy and Risk of Endometrial Hyperplasia and Endometrial Cancer
Progestin-Only Contraceptives: Effects on Weight
Progestins for Symptomatic Treatment of Endometriosis
Progestogen-Releasing Intrauterine Systems for Heavy Menstrual Bleeding
Progestogens and other Hormone Therapies in Women with Breast Cancer and Bone Metastasis
Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Steroid Hormones for Contraception in Women with Sickle Cell Disease
Subdermal Implants for Contraception